Verista’s Post

Update: Thank you, Jason Howard and Tegus team for stepping in promptly and professionally, and launching a full investigation. As partners in the broader compliance ecosystem, we at Gesund.ai value the integrity of our process and experts above all else and appreciate these principles are reflected in Tegus’ actions. ——————— I had the strangest exchange with an investor yesterday who used Tegus' expert elicitation services to conduct a competitive tech assessment on us. This is business as usual for the ecosystem; I, too, routinely get inbound requests from such providers soliciting my input on various technologies for diligence purposes. Tegus interviewed an expert - an executive from a large pharmaceutical company - who talked about their trial with us and compared us against a couple of other companies they used (I wouldn't have picked these two as direct comps but I'll leave that aside for now). Here is the kicker: not only have I never met this pharma executive, we also never worked with this pharma group in any capacity let alone a full-blown trial. Investors: do qualify your sources and references - this could have easily slipped for large companies operating in a large industry.

As dealmaking in biopharma picks up, eClinical CEO Raj Indupuri sees an opportunity for clinical software companies to make acquisitions easier to close. Check out Raj's interview with PharmaVoice's Michael Gibney to learn why data is the most valuable asset, how new technology plays a role in M&A, and ways to address challenges of the current environment: https://lnkd.in/euqUnjHr

In our industry, there’s one thing you can’t exaggerate about and that’s experience. We are often asked what sets Pharmatech Associates apart. That answer always comes back to experience—the kind that can only be earned over time in the industry trenches. We have over 25 years of leadership in the life sciences industry. We work with clients that range in size from start-ups to large multinationals. Each project is matched with subject matter experts armed with the necessary local regulatory insight to successfully commercialize products in almost any jurisdiction around the world. Yes, experience is everything in our line of work. Let’s talk today. https://hubs.ly/Q02jWLRr0 #PharmaCompliance #pharmaexpertise #pharmaconsulting

Absolutely thrilled to welcome our second acquisition of the year, Insigniam, to the Elixirr family! 💥 Insigniam's clients include one-third of the Fortune 50, over 100 of the Forbes Global 1000, and all 16 of the largest pharmaceutical companies in the world. These clients have documented more than 50x ROI in measurable results; and 85% report that Insigniam provides more value than any other consulting firm! Insigniam's incredible people work at the top of the house to inspire and achieve the cultural change necessary for breakthrough transformation. As a behavioural economist myself, I intuitively leverage heuristics and framing to inspire and accelerate human engagement and adoption. I have no doubt the application of Insigniam's proprietary methodologies will catalyse our clients' results and speed to transformation. 📈 Here's to: - Breakthrough Performance ✅🍾 - Audacious Outcomes ✅🙌 - Being Human ✅🤗 Read more here: https://lnkd.in/eRRBmsdH #acquisition #beinghuman #catalyst #performance #insigniam #msh Nathan Rosenberg Shideh Sedgh Bina Katerin Le Folcalvez Jen Zimmer

KMK disrupts pharma norms by blending secondary data with primary methods for impactful decision-making. Work with a dedicated and versatile team solely dedicated to tackling your unique challenge and gain the advantage of diverse perspectives, deep insights, and expert recommendations. Enjoy the ease of streamlined communication and a seamless onboarding process through a single point of contact. #PharmaInnovation #IntegratedInsights #Primaryresearch

Reach out to me to know how primary research can be used to enhance secondary data for a comprehensive decision making!

Thriving across diverse industry verticals, ACCELQ has empowered organizations to attain Continuous Delivery through flawless and dependable test automation. Dive into some of our standout success stories below! 🚀 https://lnkd.in/gWpuKb9Q #ACCELQ #ContinuousDelivery #TestAutomation #SuccessStories"

Tired of outdated training methods? Geistlich Pharma were too, until they discovered our GROW e-Learning platform. With 96.7% of participants loving its ease of use, GROW transformed their skills, engagement, and performance. Curious to know how? Dive into our case study to find out: https://lnkd.in/e-tVKKNC #GameChanger #SkillBoost #ClientSuccess #ELearning #ContinuousLearning #BusinessGrowth #GeistlichPharma #ExpressionForGrowth

QuVa Pharma Acquires LogicStream Health - HIT Consultant #QuVaPharma Acquires LogicStream Health #Overview QuVa Pharma, a leading 503B outsourcing facility, has recently acquired LogicStream Health, a healthcare IT company specializing in clinical process improvement software. #Benefits of Acquisition The acquisition will allow QuVa Pharma to enhance its medication management capabilities and improve patient outcomes through the integration of LogicStream Health's technology. #Integration Process The integration process will involve combining QuVa Pharma's industry expertise with LogicStream Health's innovative software solutions to streamline medication management processes. #Future Plans QuVa Pharma plans to leverage LogicStream Health's technology to expand its offerings and provide more comprehensive medication management solutions to healthcare organizations. #Impact on Healthcare IT The acquisition of LogicStream Health by Qu ai.mediformatica.com #pharma #acquisition #health #management #analytics #clinical #healthcare #healthcaresystem #hospitals #informatics #insights #learning #digitalhealth #healthit #healthtech #healthcaretechnology @MediFormatica (https://buff.ly/3VFkEJe)

Innovation is rapidly unfolding in Regulatory operations - and you can’t afford to fall behind. Join us on August 7th for a free webinar featuring two of ArisGlobal’s product leaders, Renato Rjavec and Garrett Hess, to discover how the latest advancements - including #GenAI and #LLM capabilities - can drive more than 50% efficiency gains across Regulatory operations. Register today: https://lnkd.in/ekNvHJGc  #RegulatoryAffairs #RegulatoryOperations #LifeSciences #PharmaRegulations #ClinicalResearch